New Lipid Lowering Therapies for Cardiovascular and Metabolic Diseases: Lessons from the Past and Future Challenges
Resource type: Ressourcentyp: Buch (Online)Book (Online)Language: English Publisher: [Erscheinungsort nicht ermittelbar] : MDPI - Multidisciplinary Digital Publishing Institute, 2019Description: 1 Online-Ressource (116 p.)ISBN:- 9783039216772
- 9783039216765
- Biology, life sciences
- apolipoprotein
- lipids
- risk stratification
- proprotein convertase subtilisin-kexin type 9 (PCSK9)
- vaspin
- sphingolipids
- PCSK9
- ceramides
- atrial fibrillation
- circular RNA
- STEMI
- cholesterol
- lipoproteins
- cardiovascular disease (CVD)
- coronary artery bypass grafting
- atherosclerosis
- statin
- LDL subfractions
- acute kidney injury
- dyslipidemia
- gene expression
- NSTEMI
- NAFLD
- hyperlipidemia
- nonstatin
- cholesteryl ester transfer protein
- low-density lipoprotein cholesterol
- anacetrapib
- HDL
- acute coronary syndrome
- miRNA
- cardiovascular risk
- pleiotropic actions
- genetic
- ABCA1
- sdLDL
- cardiovascular disease
- proprotein convertase subtilisin/kexin type 9
- inclisiran
- reverse cholesterol transport
- sterol
- small interfering RNA (siRNA)
- RNA-binding proteins
- cardiovascular diseases
- NASH
- low-density lipoprotein-cholesterol (LDL-C)
- stroke
- nutrigenetics
- type 2 diabetes
- statins
- sphingomyelin
- hepatic fibrosis
- diabetes
Open Access. Unrestricted online access star
Creative Commons https://creativecommons.org/licenses/by-nc-nd/4.0 cc
English